TY - JOUR
T1 - Factors affecting longitudinal functional decline and survival in amyotrophic lateral sclerosis patients
AU - Watanabe, Hazuki
AU - Atsuta, Naoki
AU - Nakamura, Ryoichi
AU - Hirakawa, Akihiro
AU - Watanabe, Hirohisa
AU - Ito, Mizuki
AU - Senda, Jo
AU - Katsuno, Masahisa
AU - Izumi, Yuishin
AU - Morita, Mitsuya
AU - Tomiyama, Hiroyuki
AU - Taniguchi, Akira
AU - Aiba, Ikuko
AU - Abe, Koji
AU - Mizoguchi, Kouichi
AU - Oda, Masaya
AU - Kano, Osamu
AU - Okamoto, Koichi
AU - Kuwabara, Satoshi
AU - Hasegawa, Kazuko
AU - Imai, Takashi
AU - Aoki, Masashi
AU - Tsuji, Shoji
AU - Nakano, Imaharu
AU - Kaji, Ryuji
AU - Sobue, Gen
N1 - Publisher Copyright:
© 2014 Informa Healthcare.
PY - 2015/6/1
Y1 - 2015/6/1
N2 - Our objective was to elucidate the clinical factors affecting functional decline and survival in Japanese amyotrophic lateral sclerosis (ALS) patients. We constructed a multicenter prospective ALS cohort that included 451 sporadic ALS patients in the analysis. We longitudinally utilized the revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R) as the functional scale, and determined the timing of introduction of a tracheostomy for positive-pressure ventilation and death. A joint modelling approach was employed to identify prognostic factors for functional decline and survival. Age at onset was a common prognostic factor for both functional decline and survival (p < 0.001, p < 0.001, respectively). Female gender (p = 0.019) and initial symptoms, including upper limb weakness (p = 0.010), lower limb weakness (p = 0.008) or bulbar symptoms (p = 0.005), were related to early functional decline, whereas neck weakness as an initial symptom (p = 0.018), non-use of riluzole (p = 0.030) and proximal dominant muscle weakness in the upper extremities (p = 0.01) were related to a shorter survival time. A decline in the ALSFRS-R score was correlated with a shortened survival time (p < 0.001). In conclusion, the factors affecting functional decline and survival in ALS were common in part but different to some extent. This difference has not been previously well recognized but is informative in clinical practice and for conducting trials.
AB - Our objective was to elucidate the clinical factors affecting functional decline and survival in Japanese amyotrophic lateral sclerosis (ALS) patients. We constructed a multicenter prospective ALS cohort that included 451 sporadic ALS patients in the analysis. We longitudinally utilized the revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R) as the functional scale, and determined the timing of introduction of a tracheostomy for positive-pressure ventilation and death. A joint modelling approach was employed to identify prognostic factors for functional decline and survival. Age at onset was a common prognostic factor for both functional decline and survival (p < 0.001, p < 0.001, respectively). Female gender (p = 0.019) and initial symptoms, including upper limb weakness (p = 0.010), lower limb weakness (p = 0.008) or bulbar symptoms (p = 0.005), were related to early functional decline, whereas neck weakness as an initial symptom (p = 0.018), non-use of riluzole (p = 0.030) and proximal dominant muscle weakness in the upper extremities (p = 0.01) were related to a shorter survival time. A decline in the ALSFRS-R score was correlated with a shortened survival time (p < 0.001). In conclusion, the factors affecting functional decline and survival in ALS were common in part but different to some extent. This difference has not been previously well recognized but is informative in clinical practice and for conducting trials.
UR - http://www.scopus.com/inward/record.url?scp=84929756081&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84929756081&partnerID=8YFLogxK
U2 - 10.3109/21678421.2014.990036
DO - 10.3109/21678421.2014.990036
M3 - Article
C2 - 25548957
AN - SCOPUS:84929756081
SN - 2167-8421
VL - 16
SP - 230
EP - 236
JO - Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
JF - Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
IS - 3-4
ER -